R-Evolution Worldwide in Africa for United Nations Sustainable Development Goal n. 3 “Ensure healthy lives and promote well-being for all at all ages”.
R-Evolution aims to contribute to African public health advances through strategic research activities. The vision is to increase the involvement of the Sub-Saharan African (SSA) countries in ethically and scientifically sound biomedical research and clinical trials addressing specifically SSA public health challenges.
R-Evolution Worldwide supports also research projects to develop new interventional treatments, medicines, vaccines, diagnostics, to improve the access to existing healthcare tools and to strenghtening research ethics and regulatory capacities.
Currently, R-Evolution Worldwide is involved in the following project consortia, all coordinated by African researchers:
|Acronym (click on it to access the website)||Project title||Status||Sub-Sharan African countries involved|
|LiberHetica||Increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes, harmonized procedures, standardized guidelines and educative training programs (grant n. CSA2018ERC-2327 EDCTP).||Completed||Liberia|
|Africlinique||A European-African network for strengthening the regulatory capacity for clinical research and pharmacovigilance in Central Africa: implementation of harmonized procedures, efficient guidelines and training programs (gent n. CSA2018ERC-2319 EDCTP)||Completed||Republic of Congo, Cameroon, (Gabon)|
|AfriEthique||A European-African network for strengthening the Ethics capacity for clinical research review in the Democratic Republic of Congo, the Republic of Central Africa, Chad, and the Republic of Congo (grant n. CSA2019ERC-2675 EDCTP).||Ongoing||Democratic Republic of Congo, the Republic of Central Africa, Chad, Republic of Congo, (Gabon)|
|ITAIL-COVID-19||Integrated Testing Approaches and Intensive Laboratory training as strategy against COVID-19 spread in Congo-Brazzaville (grant n. RIA2020EF-2947 )||Completed||Republic of Congo|
|SEARCH||Increasing the regulatory capacities for review of clinical trials in Southern Africa by establishing European-African collaborations facilitating the implementation of efficient procedures (SEARCH SouthErn Africa Regulatory for Clinical researcH) (grant n. CSA2019ERC-2688 EDCTP)||Ongoing||Mozambique, Botswana, Lesotho, Eswatini|
|INTEGRATION||INcreasing the upTakE of IPTp-SP throuGh Seasonal MalaRiA ChemoprevenTION channel delivery (RIA2020S-3302)||Ongoing||Mali, Burkina Faso|
|NeuroSolve||Neurocysticercosis Implementation Research||Proposal under development||Tanzania, Zambia|
|ADAPTIVE||Onchocerciasis Adaptive Platform Trial||Proposal under development||Cameroon, Ghana and Ivory Coast|
|CANTAM3||Central Africa Network on Tuberculosis, HIV/AIDS and Malaria||Ongoing||Republic of Congo, Cameroon, Gabon, The Democratic Republic of the Congo and Zambia|